Junior Researcher
Instituto de Investigação e Inovação em Saúde (i3S), Portugal
Soraia Pinto is a Junior Researcher at Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Portugal. She concluded her PhD in the Doctoral Program in Biomedical Sciences (Jul 2024) at Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, under a partnership between i3S and the University Medical Center Groningen, The Netherlands. Soraia Pinto also got a master’s degree in Pharmaceutical Sciences from Faculty of Pharmacy, University of Porto, in 2018. Her current areas of interest include biomaterials, type 2 diabetes mellitus-targeted therapies, and intestinal target.
Soraia Pinto has developed extensive work in the field of nanotechnology since 2018, which was translated in the publication of 19 articles in international peer reviewed journals and 3 book chapters. She also participated in national and international conferences with 29 poster presentations and 8 oral presentations, and she was recognized with 5 distinctions.
As part of her commitment to the research field, she was enrolled in the scientific committee of the Controlled Release Society (CRS) as member of the Young Scientist Committee (CRS-YSC, since 2024), and the Oral Delivery Focus Group CRS (since 2024). Currently, she is the Social Media Lead of CRS-YSC and the Communication Chair of Oral Delivery Focus group. She is also member of Spanish/Portuguese Local Chapter of CRS and Sociedade Portuguesa de Diabetologia.
